Search

everythinglearnresearchcommunity

for

Search:↓

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Frontal fibrosing alopecia can sometimes look like syphilitic hair loss.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Postmenopausal virilization can be caused by ovarian hyperthecosis, treatable with surgery.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Doctors should check for serious tumor causes of high androgen levels in postmenopausal women and more research is needed on this condition.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Most women had adequate essential elements except zinc, and lead levels were higher in peri-/post-menopausal women.

Hormone Replacement Therapy improves skin health in postmenopausal women by boosting collagen and hydration.

Ovarian tumors should be considered when postmenopausal women show signs of virilization.

Frontal Fibrosing Alopecia mainly affects postmenopausal women and is linked to thyroid disease, hyperlipidemia, and anemia.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

Trichoscopy helps diagnose frontal fibrosing alopecia, even with unusual patterns.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Menopause-related skin changes may increase fungal infections and inflammation.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Cosmetic products or emotional factors might contribute to Frontal Fibrosing Alopecia, and trichoscopy is useful for diagnosis.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

Prompt treatment of tinea capitis with oral antifungals leads to excellent recovery, but delayed care can cause permanent hair loss.

Female hair loss is influenced by genetics and hormones, often starting in middle age or after hormonal changes.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Hormone replacement therapy can improve skin aging in postmenopausal women.

Menopause can cause oral health issues like dry mouth and burning sensations.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.